• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用固体波纹颗粒增强粉末气溶胶性能。

Use of solid corrugated particles to enhance powder aerosol performance.

作者信息

Chew N Y, Chan H K

机构信息

Faculty of Pharmacy, University of Sydney, NSW, Australia.

出版信息

Pharm Res. 2001 Nov;18(11):1570-7. doi: 10.1023/a:1013082531394.

DOI:10.1023/a:1013082531394
PMID:11758765
Abstract

PURPOSE

To study the dispersion performance of non-porous corrugated particles, with a focus on the effect of particle surface morphology on aerosolization of bovine serum albumin (BSA) powders.

METHODS

The solid-state characteristics of the spray-dried BSA powders, one consisting of smooth spherical particles and another corrugated particles, were characterized by laser diffraction, X-ray powder diffraction, scanning electron microscopy, confocal microscopy, thermogravimetric analysis, surface area analyzer, and buoyancy method. The powders were dispersed using the Rotahaler and the Dinkihaler coupled to a four-stage liquid impinger operating at 30 to 120 L/min. Fine particle fraction (FPF) was expressed as the wt. % of BSA particles of size < or =5 microm collected from the liquid impinger.

RESULTS

Apart from the morphology and morphology-related properties (specific surface area, envelope density), the corrugated particles and spherical particles of BSA had very similar solid-state characteristics (particle size distribution, water content, true density, amorphous nature). Using the Dinkihaler, the FPFs of the corrugated particles were 10-20 wt. % higher than those of the smooth particles. Similar FPF differences were found for the powders dispersed by the Rotahaler, but the relative changes were larger. In addition, the differences were inversely proportional to the air flows (17.3% at 30 L/min, 25.2% at 60 L/min, 13.8% at 90, 8.5% at 120 L/min). Depending on the inhaler, capsule and device retention and impaction loss at the impinger throat were lower for the corrugated particles.

CONCLUSIONS

Enhanced aerosol performance of powders can be obtained by surface modification of the particles. The surface asperities of the corrugated particles could lower the true area of contact between the particles, and thus reduce the powder cohesiveness. A distinct advantage of using corrugated particles is that the inhaler choice and air flow become less critical for these particles.

摘要

目的

研究无孔波纹颗粒的分散性能,重点关注颗粒表面形态对牛血清白蛋白(BSA)粉末雾化的影响。

方法

采用激光衍射、X射线粉末衍射、扫描电子显微镜、共聚焦显微镜、热重分析、表面积分析仪和浮力法对喷雾干燥的BSA粉末的固态特性进行表征,其中一种粉末由光滑球形颗粒组成,另一种由波纹颗粒组成。使用旋转吸入器和丁基吸入器将粉末分散,并与以30至120 L/min运行的四级液体冲击器相连。细颗粒分数(FPF)表示为从液体冲击器收集的尺寸小于或等于5微米的BSA颗粒的重量百分比。

结果

除形态及与形态相关的特性(比表面积、堆积密度)外,BSA的波纹颗粒和球形颗粒具有非常相似的固态特性(粒度分布、含水量、真密度、无定形性质)。使用丁基吸入器时,波纹颗粒的FPF比光滑颗粒高10%-20%。对于通过旋转吸入器分散的粉末,也发现了类似的FPF差异,但相对变化更大。此外,这些差异与气流成反比(30 L/min时为17.3%,60 L/min时为25.2%,90 L/min时为13.8%,120 L/min时为8.5%)。根据吸入器的不同,波纹颗粒在胶囊和装置中的滞留以及在冲击器喉部的撞击损失较低。

结论

通过颗粒表面改性可提高粉末的雾化性能。波纹颗粒的表面粗糙度可降低颗粒之间的实际接触面积,从而降低粉末的内聚性。使用波纹颗粒的一个明显优势是,对于这些颗粒,吸入器的选择和气流变得不那么关键。

相似文献

1
Use of solid corrugated particles to enhance powder aerosol performance.使用固体波纹颗粒增强粉末气溶胶性能。
Pharm Res. 2001 Nov;18(11):1570-7. doi: 10.1023/a:1013082531394.
2
Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.颗粒大小、气流及吸入装置对甘露醇粉末作为气雾剂分散的影响。
Pharm Res. 1999 Jul;16(7):1098-103. doi: 10.1023/a:1018952203687.
3
Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.颗粒大小、气流及吸入装置对色甘酸钠粉末雾化的影响。
Int J Pharm. 2000 Sep 25;206(1-2):75-83. doi: 10.1016/s0378-5173(00)00516-0.
4
How much particle surface corrugation is sufficient to improve aerosol performance of powders?多少颗粒表面波纹度足以改善粉末的气溶胶性能?
Pharm Res. 2005 Jan;22(1):148-52. doi: 10.1007/s11095-004-9020-4.
5
Force control and powder dispersibility of spray dried particles for inhalation.喷雾干燥颗粒吸入剂的力控和粉末分散性。
J Pharm Sci. 2010 Jan;99(1):303-16. doi: 10.1002/jps.21849.
6
The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations.药物形态对干粉吸入剂制剂雾化效率的影响。
J Pharm Sci. 2008 Jul;97(7):2780-8. doi: 10.1002/jps.21195.
7
Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
Pharm Res. 1997 Apr;14(4):431-7. doi: 10.1023/a:1012035113276.
8
Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.用于靶向肺部递送的先进喷雾干燥微粒/纳米微粒甘露醇粉末作为干粉吸入器的设计、表征和气溶胶分散性能建模。
J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):81-93. doi: 10.1089/jamp.2013.1078. Epub 2014 Feb 6.
9
Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.水分诱导结晶对喷雾干燥无定形环丙沙星粉末制剂气溶胶性能的影响。
Pharm Res. 2018 Jan 2;35(1):7. doi: 10.1007/s11095-017-2281-5.
10
L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.L-亮氨酸作为一种辅料对高吸湿性喷雾干燥粉末体外雾化性能的防潮作用。
Eur J Pharm Biopharm. 2016 May;102:132-41. doi: 10.1016/j.ejpb.2016.02.010. Epub 2016 Mar 9.

引用本文的文献

1
Evaluation of the Combination of L‑leucine to Chitosan on Sustained Release of Inhalable Heparin Sodium Microparticles.L-亮氨酸与壳聚糖组合对可吸入肝素钠微粒缓释作用的评价
Pharm Res. 2025 Jul 1. doi: 10.1007/s11095-025-03883-7.
2
Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder.用于开发扁球形可吸入粉末的大麻二酚与羟丙基-β-环糊精
AAPS J. 2025 Jan 17;27(1):30. doi: 10.1208/s12248-025-01015-y.
3
Innovative Dual Combination Cospray-Dried Rock Inhibitor/l-Carnitine Inhalable Dry Powder Aerosols.

本文引用的文献

1
Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.颗粒大小、气流及吸入装置对色甘酸钠粉末雾化的影响。
Int J Pharm. 2000 Sep 25;206(1-2):75-83. doi: 10.1016/s0378-5173(00)00516-0.
2
Formulation and physical characterization of large porous particles for inhalation.用于吸入的大孔颗粒的配方及物理特性
Pharm Res. 1999 Nov;16(11):1735-42. doi: 10.1023/a:1018910200420.
3
Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive.
创新型双组合共喷雾干燥岩石抑制剂/左旋肉碱可吸入干粉气雾剂。
ACS Bio Med Chem Au. 2024 Oct 28;4(6):300-318. doi: 10.1021/acsbiomedchemau.4c00063. eCollection 2024 Dec 18.
4
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.干粉吸入器中使用的不同载体:其颗粒特性
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):307-327. doi: 10.1089/jamp.2023.0029. Epub 2024 Aug 9.
5
Evaluating the effect of sodium alginate and sodium carboxymethylcellulose on pulmonary delivery of levofloxacin spray-dried microparticles.评价海藻酸钠和羧甲基纤维素钠对盐酸左氧氟沙星喷雾干燥微球肺部给药的影响。
Daru. 2024 Dec;32(2):557-571. doi: 10.1007/s40199-024-00526-x. Epub 2024 Jul 2.
6
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration.抗分枝杆菌药物贝达喹啉肺部给药途径的制剂策略
Pharmaceuticals (Basel). 2023 May 11;16(5):729. doi: 10.3390/ph16050729.
7
Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma.表面修饰的吸入式微囊包裹雷公藤红素用于增强恶性胸膜间皮瘤的疗效。
Int J Mol Sci. 2023 Mar 8;24(6):5204. doi: 10.3390/ijms24065204.
8
Mannitol Is a Good Anticaking Agent for Spray-Dried Hydroxypropyl-Beta-Cyclodextrin Microcapsules.甘露醇是喷雾干燥羟丙基-β-环糊精微胶囊的优良抗结块剂。
Molecules. 2023 Jan 22;28(3):1119. doi: 10.3390/molecules28031119.
9
Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model.用于小鼠模型中肺炎鼠疫治疗的庆大霉素喷雾干燥可吸入粉末制剂。
Pharmaceutics. 2022 Nov 29;14(12):2646. doi: 10.3390/pharmaceutics14122646.
10
Production of Inhalable Ultra-Small Particles for Delivery of Anti-Inflammation Medicine via a Table-Top Microdevice.通过桌面微型装置生产用于递送抗炎药物的可吸入超小颗粒。
Micromachines (Basel). 2022 Aug 25;13(9):1382. doi: 10.3390/mi13091382.
Pharm Res. 1999 Oct;16(10):1643-7. doi: 10.1023/a:1011981326827.
4
Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.颗粒大小、气流及吸入装置对甘露醇粉末作为气雾剂分散的影响。
Pharm Res. 1999 Jul;16(7):1098-103. doi: 10.1023/a:1018952203687.
5
Inhalation of estradiol for sustained systemic delivery.吸入雌二醇以实现持续的全身给药。
J Aerosol Med. 1999 Spring;12(1):27-36. doi: 10.1089/jam.1999.12.27.
6
Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.流速对压力定量吸入器和呼吸驱动吸入器产生的气溶胶粒径分布的影响。
J Aerosol Med. 1998 Winter;11(4):231-45. doi: 10.1089/jam.1998.11.231.
7
Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs.
Pharm Res. 1999 Apr;16(4):555-61. doi: 10.1023/a:1018879331061.
8
Protein inhalation powders: spray drying vs spray freeze drying.蛋白质吸入粉剂:喷雾干燥与喷雾冷冻干燥
Pharm Res. 1999 Feb;16(2):249-54. doi: 10.1023/a:1018828425184.
9
The effect of operating and formulation variables on the morphology of spray-dried protein particles.操作和配方变量对喷雾干燥蛋白质颗粒形态的影响。
Pharm Dev Technol. 1997 Aug;2(3):213-23. doi: 10.3109/10837459709031441.
10
Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols.颗粒形态对脂肪酸处理的色甘酸钠粉末气雾剂释放剂量的影响。
Pharm Dev Technol. 1997 Feb;2(1):67-79. doi: 10.3109/10837459709022610.